A recent study aimed to evaluate how the disease burden of Friedreich's ataxia changes over time and identify factors associated with its progression. This study used a remote approach, allowing for continuous monitoring without in-person visits, which could provide insights into real-world disease progression.
The study's focus on remote monitoring could help in understanding factors influencing disease progression, crucial for developing more effective management strategies. By analyzing changes in disease burden, researchers can tailor treatments to individual needs, improving quality of life for those affected. This research contributes to ongoing efforts to manage and potentially slow the progression of Friedreich's ataxia, as reported by Monickaraj et al. (2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:
More Info 
Add to Calendar 